Search Results | Clinical Cancer Research | American Association for Cancer Research

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Phase I Trial of a Novel Anti-HER2 Antibody–Drug Conjugate, ARX788, for the Treatment of HER2-Positive Metastatic Breast Cancer

Jian Zhang, Dongmei Ji, Weina Shen, Qin Xiao, Yajia Gu, Joyce O'Shaughnessy, Xichun Hu

Clin Cancer Res OF1–OF10.

DOI: https://doi.org/10.1158/1078-0432.CCR-22-0456

Published: 29 June 2022

View article

Includes: Supplementary data

Journal Articles

Trilaciclib Prior to Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer: Final Efficacy and Subgroup Analysis from a Randomized Phase II Study

Antoinette R. Tan, Gail S. Wright, Anu R. Thummala, Michael A. Danso, Lazar Popovic, Timothy J. Pluard, Hyo S. Han, Željko Vojnović, Nikola Vasev, Ling Ma, Donald A. Richards, Sharon T. Wilks, Dušan Milenković, Jie Xiao, Jessica Sorrentino, Janet Horton, Joyce O'Shaughnessy

Clin Cancer Res (2022) 28 (4): 629–636.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-2272

Published: 06 December 2021

View article

Includes: Supplementary data

Journal Articles

Baseline Characteristics, Treatment Patterns, and Outcomes in Patients with HER2-Positive Metastatic Breast Cancer by Hormone Receptor Status from SystHERs

Melody Cobleigh, Denise A. Yardley, Adam M. Brufsky, Hope S. Rugo, Sandra M. Swain, Peter A. Kaufman, Debu Tripathy, Sara A. Hurvitz, Joyce O'Shaughnessy, Ginny Mason, Vincent Antao, Haocheng Li, Laura Chu, Mohammad Jahanzeb

Clin Cancer Res (2020) 26 (5): 1105–1113.

DOI: https://doi.org/10.1158/1078-0432.CCR-19-2350

Published: 02 March 2020

View article

Includes: Supplementary data

Journal Articles

Central Nervous System Metastasis in Patients with HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from SystHERs

Sara A. Hurvitz, Joyce O'Shaughnessy, Ginny Mason, Denise A. Yardley, Mohammad Jahanzeb, Adam Brufsky, Hope S. Rugo, Sandra M. Swain, Peter A. Kaufman, Debu Tripathy, Laura Chu, Haocheng Li, Vincent Antao, Melody Cobleigh

Clin Cancer Res (2019) 25 (8): 2433–2441.

DOI: https://doi.org/10.1158/1078-0432.CCR-18-2366

Published: 15 April 2019

View article

Includes: Supplementary data

Journal Articles

Change in Topoisomerase 1–Positive Circulating Tumor Cells Affects Overall Survival in Patients with Advanced Breast Cancer after Treatment with Etirinotecan Pegol

Hope S. Rugo, Javier Cortes, Ahmad Awada, Joyce O'Shaughnessy, Chris Twelves, Seock-Ah Im, Alison Hannah, Lin Lu, Sherwin Sy, Katie Caygill, Deborah A. Zajchowski, Darren W. Davis, Mary Tagliaferri, Ute Hoch, Edith A. Perez

Clin Cancer Res (2018) 24 (14): 3348–3357.

DOI: https://doi.org/10.1158/1078-0432.CCR-17-3059

Published: 15 July 2018

View article

Includes: Supplementary data

Journal Articles

MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR⁺/HER2⁻ Metastatic Breast Cancer

Maura N. Dickler, Sara M. Tolaney, Hope S. Rugo, Javier Cortés, Véronique Diéras, Debra Patt, Hans Wildiers, Clifford A. Hudis, Joyce O'Shaughnessy, Esther Zamora, Denise A. Yardley, Martin Frenzel, Andrew Koustenis, José Baselga

Clin Cancer Res (2017) 23 (17): 5218–5224.

DOI: https://doi.org/10.1158/1078-0432.CCR-17-0754

Published: 31 August 2017

View article

Includes: Supplementary data

Journal Articles

Biomarker Associations with Efficacy of Abiraterone Acetate and Exemestane in Postmenopausal Patients with Estrogen Receptor–Positive Metastatic Breast Cancer

Clin Cancer Res (2016) 22 (24): 6002–6009.

DOI: https://doi.org/10.1158/1078-0432.CCR-15-2452

Published: 15 December 2016

View article

Includes: Supplementary data

Journal Articles

Patients with Slowly Proliferative Early Breast Cancer Have Low Five-Year Recurrence Rates in a Phase III Adjuvant Trial of Capecitabine

Joyce O'Shaughnessy, Hartmut Koeppen, Yuanyuan Xiao, Mark R. Lackner, Devchand Paul, Christopher Stokoe, John Pippen, Jr, Lea Krekow, Frankie Ann Holmes, Svetislava Vukelja, Deborah Lindquist, Scot Sedlacek, Ragene Rivera, Robert Brooks, Kristi McIntyre, Carrie Brownstein, Silke Hoersch, Joanne L. Blum, Stephen Jones

Clin Cancer Res (2015) 21 (19): 4305–4311.

DOI: https://doi.org/10.1158/1078-0432.CCR-15-0636

Published: 30 September 2015

View article

Includes: Supplementary data

Journal Articles

Poly (ADP-Ribose) Polymerase as a Novel Therapeutic Target in Cancer

Christina M. Annunziata, Joyce O'Shaughnessy

Clin Cancer Res (2010) 16 (18): 4517–4526.

DOI: https://doi.org/10.1158/1078-0432.CCR-10-0526

Published: 14 September 2010

View article

Journal Articles

Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move Forward

Clin Cancer Res (2006) 12 (12): 3661–3697.

DOI: https://doi.org/10.1158/1078-0432.CCR-06-1104

Published: 15 June 2006

View article

Journal Articles

The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development

Gary J. Kelloff, Kenneth A. Krohn, Steven M. Larson, Ralph Weissleder, David A. Mankoff, John M. Hoffman, Jeanne M. Link, Kathryn Z. Guyton, William C. Eckelman, Howard I. Scher, Joyce O'Shaughnessy, Bruce D. Cheson, Caroline C. Sigman, James L. Tatum, George Q. Mills, Daniel C. Sullivan, Janet Woodcock

Clin Cancer Res (2005) 11 (22): 7967–7985.

DOI: https://doi.org/10.1158/1078-0432.CCR-05-1302

Published: 18 November 2005

View article

Journal Articles

Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development

Gary J. Kelloff, John M. Hoffman, Bruce Johnson, Howard I. Scher, Barry A. Siegel, Edward Y. Cheng, Bruce D. Cheson, Joyce O'Shaughnessy, Kathryn Z. Guyton, David A. Mankoff, Lalitha Shankar, Steven M. Larson, Caroline C. Sigman, Richard L. Schilsky, Daniel C. Sullivan

Clin Cancer Res (2005) 11 (8): 2785–2808.

DOI: https://doi.org/10.1158/1078-0432.CCR-04-2626

Published: 18 April 2005

View article

Journal Articles

Paclitaxel Chemotherapy after Autologous Stem-Cell Transplantation and Engraftment of Hematopoietic Cells Transduced with a Retrovirus Containing the Multidrug Resistance Complementary DNA (MDR1) in Metastatic Breast Cancer Patients

Clin Cancer Res (1999) 5 (7): 1619–1628.

Published: 01 July 1999

View article

NARROW

Phase I Trial of a Novel Anti-HER2 Antibody–Drug Conjugate, ARX788, for the Treatment of HER2-Positive Metastatic Breast Cancer

Trilaciclib Prior to Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer: Final Efficacy and Subgroup Analysis from a Randomized Phase II Study

Baseline Characteristics, Treatment Patterns, and Outcomes in Patients with HER2-Positive Metastatic Breast Cancer by Hormone Receptor Status from SystHERs

Central Nervous System Metastasis in Patients with HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from SystHERs

Change in Topoisomerase 1–Positive Circulating Tumor Cells Affects Overall Survival in Patients with Advanced Breast Cancer after Treatment with Etirinotecan Pegol

MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR⁺/HER2⁻ Metastatic Breast Cancer

Biomarker Associations with Efficacy of Abiraterone Acetate and Exemestane in Postmenopausal Patients with Estrogen Receptor–Positive Metastatic Breast Cancer

Patients with Slowly Proliferative Early Breast Cancer Have Low Five-Year Recurrence Rates in a Phase III Adjuvant Trial of Capecitabine

Poly (ADP-Ribose) Polymerase as a Novel Therapeutic Target in Cancer

Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move Forward

The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development

Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development

Paclitaxel Chemotherapy after Autologous Stem-Cell Transplantation and Engraftment of Hematopoietic Cells Transduced with a Retrovirus Containing the Multidrug Resistance Complementary DNA (MDR1) in Metastatic Breast Cancer Patients

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only